Citi raised the firm’s price target on Sotera Health (SHC) to $21 from $17 and keeps a Neutral rating on the shares. The firm adjusted models in the life science tools and diagnostics group ahead of the Q3 reports.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHC: